Hidradenitis Suppurativa Video Roundtable

This 4-part video series on hidradenitis suppurativa (HS) features a roundtable discussion among dermatologists on this chronic inflammatory condition that has a significant impact on the quality of life of patients. Moderated by Jeffrey M. Weinberg, MD, this series covers pathogenesis, comorbidities, diagnosis, treatment, and patient education.

This video roundtable was produced by the Custom Programs division of Frontline Medical Communications.
The editorial staff of Dermatology News was not involved in developing the video roundtable.

Jeffrey M. Weinberg, MD, Moderator

Associate Clinical Professor of Dermatology

Department of Dermatology

Mount Sinai St. Luke's

Mount Sinai Beth Israel

Robert G. Micheletti, MD

Assistant Professor of Dermatology and Medicine

University of Pennsylvania Perelman School of Medicine

Member of the Board of Directors, HS Foundation

George Han, MD, PhD

Attending Physician

Department of Dermatology

Icahn School of Medicine at Mount Sinai - Mount Sinai Beth Israel

Mary Ruth Buchness, MD

Past President of the New York State Society of Dermatology and Dermatologic Surgery

Assistant Clinical Professor of Dermatology

Columbia University College of Physicians & Surgeons

Disclosure: The faculty received modest honoraria from Frontline Medical Communications for their time participating in this roundtable, and maintained complete editorial control over all content presented.

Dr. Weinberg discloses that he has received honoraria from AbbVie Inc.
Dr. Buchness discloses that she is on the speakers’ bureau for AbbVie Inc.
Dr. Micheletti and Dr. Han have nothing to disclose.

Part 1 of 4: Pathogenesis and Comorbidities of HS

The panelists review HS basics such as the median age of onset and gender prevalence. Pathological mechanisms are reviewed as well as local and systemic comorbidities. The psychosocial impact on patients also is discussed as a comorbidity, with an emphasis on coordinated care with primary care physicians and psychiatrists.

Part 2 of 4: Diagnosis of and Case Reports in HS

Learn more about identifying HS, the challenges of diagnosis, and the impact of late recognition of HS. The involvement of the HS Foundation in patient education and reimbursement issues also is discussed. The panelists provide anecdotes from cases of HS they have treated.

Part 3 of 4: Traditional Treatments of HS

The third video reviews first-line HS treatment options for patients with mild to moderate disease, including dietary changes, smoking cessation, and topical regimens. The rationale for antibiotic use also is discussed. The use of retinoids, lasers, surgery, and other skin procedures is covered.

Part 4 of 4: New Treatment Options for HS and Patient Education

The final video covers new treatment options for moderate to severe HS, including biologics, as well as other promising therapies on the horizon. Social and psychological issues such as depression, anxiety, isolation, and sexual health also are discussed. Patient education on the pathogenesis of the disease and compliance with treatment are emphasized.